HIND Vyome Holdings, Inc.

-

Vyome Reported Earnings

Thursday, November 12, 2026 · 12:00 AM ET

Vyome (HIND) reported a loss of $0.13 per share on revenue of $0.06 million for the third quarter ended September 2026. . Revenue grew 65.71% on a year-over-year basis.

Vyome Therapeutics Inc. is a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases principally in the US. Vyome Therapeutics Inc., formerly known as ReShape Lifesciences Inc., is based in CAMBRIDGE, Mass.

Earnings Whisper Grade —
Power Rating—
Reported Earnings
($0.13)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth95.8 %
Reported Revenue
$0.06M
Revenue Estimate
—
Revenue Surprise
Revenue Growth65.7 %